Sarcoma Drugs Market Size, Share & Industry Analysis, By Drug (Imatinib, Pazopanib, Ripretinib, Nirogacestat, Trabectedin, Avapritinib, & Others), By Drug Class (Cytotoxic Chemotherapy, Tyrosine Kinase Inhibitors, Gamma Secretase Inhibitors, Immune Checkpoint Inhibitors, EZH2 Inhibitors), By Disease Indication (GIST, Leiomyosarcoma, Liposarcoma, Desmoid Tumors), By Age Group (Pediatric and Adults), By Therapy (Targeted Therapy, Immunotherapy, Chemotherapy), By Route of Administration, By Distribution Channel (Hospital Pharmacies, Retail/Online Pharmacies), and Regional Forecast, 2026-2034